TP53 and glioblastoma: Interestingly, they found the combination treatment was more effective in the PTEN model than the p53 model, potentially highlighting a subgroup of patients that may benefit in the clinic.48 This study highlights the unique versatility of GEMMs and their utility in interrogating various aspects of GBM biology.